home / stock / sght / sght news

SGHT News and Press, Sight Sciences Inc. From 01/07/24

Stock Information
Company Name: Sight Sciences Inc.
Stock Symbol: SGHT
Market: NASDAQ
Website: sightsciences.com
Menu
SGHT SGHT Quote SGHT Short SGHT News SGHT Articles SGHT Message Board
Get SGHT Alerts

News, Short Squeeze, Breakout and More Instantly...
SGHT - It's JPM time! Which medtechs are expected to issue updates this week?

2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...
SGHT - Sight Sciences says no change in Medicare coverage for glaucoma procedure

2023-12-28 10:11:14 ET More on Sight Sciences Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript Sight Sciences climbs after update on Medicare coverage for glaucoma procedure Sight Sciences spikes after insider purchases Seeking Alpha’s Quan...

SGHT - Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative Contractors

MENLO PARK, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, supports the dec...

SGHT - NDRA, LITM and SNCE among mid-day movers

2023-12-26 13:19:25 ET Gainers: RayzeBio ( RYZB ) +101% . IMAC Holdings ( BACK ) +73% . Bit Brother Limited ( BETS ) +63% . Gracell Biotechnological ( GRCL ) +60% . Volcon ( VLCN ) +54% . Sight Sciences ( SGHT ) +45% ...
SGHT - Sight Sciences climbs after update on Medicare coverage for glaucoma procedure

2023-12-26 12:21:27 ET More on Sight Sciences Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript Sight Sciences spikes after insider purchases Sight Sciences slumps amid risk for Medicare coverage for glaucoma procedure Seeking Alpha’s Quant ...

SGHT - Sight Sciences Announces the Publication of Successful Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease

MENLO PARK, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients...

SGHT - Sight Sciences Announces the Acceptance for Publication of GEMINI 2, a Three Year, Prospective, Multicenter Trial Demonstrating Sustained, Significant IOP and Medication Reductions Enabled with the OMNI® Surgical System Technology

Prospective, long-term trial results are consistent with the significant body of published clinical evidence demonstrating the durable safety and effectiveness of procedures enabled with the OMNI Surgical System technology MENLO PARK, Calif., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Sight Scienc...
SGHT - November Winners

2023-12-02 12:30:00 ET Summary The average stock in the large-cap Russell 1,000 rose 9.77% in November, and 38 stocks gained more than 30%, 14 rallied more than 40%, and seven surged more than 50%. We've expanded the universe to show the top-performing stocks in the Russell 3000 i...

SGHT - Sight Sciences spikes after insider purchases

2023-11-24 13:07:26 ET More on Sight Sciences Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript Sight Sciences slumps amid risk for Medicare coverage for glaucoma procedure Piper Sandler cuts Sight Sciences to neutral, cites lowered guidance Seekin...

SGHT - Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript

2023-11-11 12:38:03 ET Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Conference Call November 07, 2023 04:30 PM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group Paul Badawi - Founder and Chief Executive Officer Ali Bauerlein - Chief Fina...
Previous 10 Next 10